|
|
Phenanthrene
Cas No. 85-01-8
Potential sources and exposures
Phenanthrene is a polycyclic aromatic hydrocarbon (PAH). The reader should
refer to the general profile on PAHs for exposure information.
Physical and chemical properties
Value
Property
Molecular weight
178.2 g/mol
Water solubility
1.00 mg/L at 21 C
6.8 10-4 atm at 25 C
Vapor pressure
Koc
14,000 mL/g
log Kow
4.46
1.59 10-4 atm-m3/mol at 25 oC
Henry's Law Constant
Toxicity
There are no data on the toxicity of phenanthrene to humans (IARC 1983).
Phenanthrene has been tested for carcinogenicity in laboratory animals by the
oral, dermal, and subcutaneous routes of administration (as cited in IARC 1983);
however, IARC (1983) and USEPA (IRIS 1992) concluded that data from
available studies were inadequate to permit an evaluation of its carcinogenicity
of phenanthrene. In addition, the results of short-term mutagenicity tests are
equivocal. Nonetheless, current theories regarding the mechanisms of metabolic
activation of PAHs predict that phenanthrene may have carcinogenic potential
(IRIS 1992).
Toxicokinetics
In general, many polycyclic aromatic hydrocarbon can produce toxicity after
inhalation, oral, or dermal exposure. Thus, it is believed that PAHs are absorbed
after exposure by these routes. Because of their high lipid solubility, PAHs are
believed to be distributed throughout the body. Relative to other tissues, they
tend to localize in body fat and fatty tissues. PAHs are generally metabolized by
the microsomal mixed function oxidase system and eliminated via the
hepatobiliary tract.
Several metabolites of phenanthrene have been identified. They include the
1,2- 3,4- and 9,10-dihydrodiols, and the 1,2-diol-3,4-epoxide. The dihydrodiols
displayed little or no tumor-initiating activity on mouse skin (IARC 1983). The
epoxide was found to be mutagenic in bacterial and mammalian cells (IARC
1983). USEPA (1982) reported significant tumorigenic activity with the
expoxide but not with phenanthrene itself in newborn mice.
D61
Appendix D Toxicological Profiles
|
Privacy Statement - Press Release - Copyright Information. - Contact Us - Support Integrated Publishing |